The New York Times reported that India-based Bharat Biotech, which has the Covaxin COVID-19 vaccine authorized in India and elsewhere, may offer even stronger protection against the virus with its experimental nasal vaccine.
Get the full story at our sister site, Drug Delivery Business News.
Mucosa and relevant structures. Image from Wikipedia.
Because of the way they provide protection, nasal vaccines are being considered as the best long-term way to prevent COVID-19 infection.
The New York Times reported that India-based Bharat Biotech, which has the Covaxin COVID-19 vaccine authorized in India and elsewhere, may offer even stronger protection against the virus with its experimental nasal vaccine.
Get the full story at our sister site, Drug Delivery Business News.